Advertisement
Loading...

Acarix AB (publ)

ACIXFPNK
Healthcare
Medical - Devices
$0.02
$0.00(0.00%)
U.S. Market opens in 15h 10m

Acarix AB (publ) Fundamental Analysis

Acarix AB (publ) (ACIXF) shows moderate financial fundamentals with a PE ratio of -6.00, profit margin of -5.31%, and ROE of -1.06%. The company generates $0.0B in annual revenue with strong year-over-year growth of 18.69%.

Key Strengths

Cash Position93.71%
PEG Ratio-0.01
Current Ratio5.72

Areas of Concern

ROE-1.06%
Operating Margin-5.27%
We analyze ACIXF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -455.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-455.7/100

We analyze ACIXF's fundamental strength across five key dimensions:

Efficiency Score

Weak

ACIXF struggles to generate sufficient returns from assets.

ROA > 10%
-98.49%

Valuation Score

Excellent

ACIXF trades at attractive valuation levels.

PE < 25
-6.00
PEG Ratio < 2
-0.01

Growth Score

Excellent

ACIXF delivers strong and consistent growth momentum.

Revenue Growth > 5%
18.69%
EPS Growth > 10%
40.61%

Financial Health Score

Excellent

ACIXF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
5.72

Profitability Score

Weak

ACIXF struggles to sustain strong margins.

ROE > 15%
-106.02%
Net Margin ≥ 15%
-5.31%
Positive Free Cash Flow
No

Key Financial Metrics

Is ACIXF Expensive or Cheap?

P/E Ratio

ACIXF trades at -6.00 times earnings. This suggests potential undervaluation.

-6.00

PEG Ratio

When adjusting for growth, ACIXF's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Acarix AB (publ) at 6.96 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.96

EV/EBITDA

Enterprise value stands at -7.05 times EBITDA. This is generally considered low.

-7.05

How Well Does ACIXF Make Money?

Net Profit Margin

For every $100 in sales, Acarix AB (publ) keeps $-5.31 as profit after all expenses.

-5.31%

Operating Margin

Core operations generate -5.27 in profit for every $100 in revenue, before interest and taxes.

-5.27%

ROE

Management delivers $-1.06 in profit for every $100 of shareholder equity.

-1.06%

ROA

Acarix AB (publ) generates $-98.49 in profit for every $100 in assets, demonstrating efficient asset deployment.

-98.49%

Following the Money - Real Cash Generation

Operating Cash Flow

Acarix AB (publ) generates limited operating cash flow of $-34.08M, signaling weaker underlying cash strength.

$-34.08M

Free Cash Flow

Acarix AB (publ) generates weak or negative free cash flow of $-35.77M, restricting financial flexibility.

$-35.77M

FCF Per Share

Each share generates $-0.03 in free cash annually.

$-0.03

FCF Yield

ACIXF converts -15.21% of its market value into free cash.

-15.21%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.96

vs 25 benchmark

P/S Ratio

Price to sales ratio

30.53

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.06

vs 25 benchmark

ROA

Return on assets percentage

-0.98

vs 25 benchmark

ROCE

Return on capital employed

-1.15

vs 25 benchmark

How ACIXF Stacks Against Its Sector Peers

MetricACIXF ValueSector AveragePerformance
P/E Ratio-6.0029.05 Better (Cheaper)
ROE-106.02%746.00% Weak
Net Margin-531.04%-49783.00% (disorted) Weak
Debt/Equity0.000.40 Strong (Low Leverage)
Current Ratio5.724.00 Strong Liquidity
ROA-98.49%-21578.00% (disorted) Weak

ACIXF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Acarix AB (publ)'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-67.93%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

89.06%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

87.53%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ